Anti-Germ & Medentech
Entry
2015
Hold
2yr
Exit
2017
Who owns Anti-Germ & Medentech?
Anti-Germ & Medentech was owned by Paragon Partners through Paragon Fund II (2014 vintage) from 2015 to 2017, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-02
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017
More from Paragon Fund II
Other portfolio companies in the same fund.
Apontis Pharma
Exited 2024
Pharma
Germany· 2018
Germany· 2018to
Asic Robotics
Exited 2026
Industrials
Switzerland· 2018
Switzerland· 2018to
inprotec
Exited 2022
IndustrialsGermany· 2018
Germany· 2018to
Unicepta
Exited 2024
Business ServicesGermany· 2018
Germany· 2018to
chicco di caffe
Exited 2023
Business ServicesGermany· 2017
Germany· 2017to
Condecta
Exited 2024
Business ServicesSwitzerland· 2017
Switzerland· 2017to
More PE-backed in Industrials
Comparable industrials deals from other GPs.
UK
US
Track Anti-Germ & Medentech
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Anti-Germ & Medentech?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Anti-Germ & Medentech.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue